The invention relates to the general field of bandages and other wound covers. More particularly, the invention relates to the field of wound contact devices that are placed in direct contact with a wound under bandages or under sealing covers for use in suction-assisted or negative pressure wound therapy.
Wound healing is a basic reparative process. It has been known throughout time that dressing wounds with appropriate materials aids the natural regenerative process. Historically, such materials have been made from cotton fibers such as gauze. These dressings are beneficial to the healing process because they insulate damaged tissue from external contaminants and because they remove potentially deleterious wound exudates.
As science and medicine have advanced, the technology incorporated into wound healing devices has improved substantially. Highly absorbent wound contact devices capable of absorbing many times their weight in liquids are available. Systems that temporarily seal wounds and utilize suction to remove exudates have found widespread utilization. Devices incorporating anti-microbial agents and biologic healing agents are common. Devices that provide a moist wound environment for improved healing have been found to be useful.
Nevertheless, many common conventional and state-of-the-art wound contact devices have shortcomings, particular for use in suction wound therapy. In an example, gauze and other similar flat fabric materials are commonly used in wound dressings. When gauze in contact with a wound becomes wet with wound exudates, it becomes soggy and soft, losing any structure it may have had and leaving little or no space above the wound surface for new tissue growth to occur. When suction is applied to a gauze wound dressing, the dressing is compressed into a flattened state and any space between the gauze fibers is effectively eliminated. Additionally, even when wound exudates are being removed by suction from a gauze dressing, the gauze remains saturated and pressed against the wound, leaving no space above the wound and thus inhibiting new tissue growth.
In another example, a dressing using a foam material in contact with the wound retains only a minimal amount of small pores at the wound contact surface when suction is applied to the dressing. When a foam dressing is used with suction, the pores of the foam collapse, eliminating space above the wound surface. Absent significant open space above the wound surface, new tissue grows into the foam. Routine removal of the foam dressing causes disruption of new tissue, excessive bleeding, and unnecessary discomfort to the patient. In-growth of tissue into foam is a significant problem because the tissue has nowhere to grow but into the collapsed cell or pore structure of the foam.
In another example, a dressing using a wound contact device in the form of a relatively rigid perforated sheet, such as an Aquaplast sheet, as a substrate in contact with the wound, is not sufficiently flexible and conformable to comfortably and adequately conform to wound surfaces that are often irregular in contour. A dressing having such an inflexible or rigid structured material or wound contact layer causes unnecessary pain and discomfort in a patient. In addition, an Aquaplast or similar sheet is constructed from solid plastic with large holes punched into the plastic. Such a sheet does not have small interconnecting interstices that facilitate the transport of liquid wound exudates away from the surface of the wound. The holes in the Aquaplast sheet simply create reservoirs where deleterious wound exudates can pool and impede wound healing. Because these large holes do not fluidically communicate with each other, fluid removal is not practical. In addition, an Aquaplast sheet does not provide any wicking for the effective removal of wound exudates. Further, an Aquaplast sheet is not permeable to either gas or liquids, and thus does not permit a wound to breath in the places where the sheet material is in contact with the wound surface, nor does it enable efficient transport of fluids and wound exudates away from the wound.
A wound dressing for use in suction wound therapy preferably has some or all of the following characteristics and properties: the dressing should be flexible and conformable to the wound, the dressing should effectively enable transport of wound exudates away from the wound surface, and the dressing should allow sufficient voids above the wound when suction is applied for unobstructed new tissue growth. The dressing should maintain structural integrity when moist and should have a geometry to actively encourage tissue growth. When used in the later stages of tissue regeneration, the dressing should inhibit or minimize entanglement of healthy new tissue into the dressing material. Early in the treatment of some wounds, there may be necrotic or dead tissue in the wound. This dead tissue can be a source of nourishment for deleterious bacteria. A dressing for treating such wounds may have a wound contact surface adapted to debride or remove dead tissue out of the wound.
As described in U.S. patent application Ser. No. 10/982,346, commonly assigned with this application and from which this application is a continuation in part, wound dressings and wound contact devices have been developed to replace traditional gauze or foam pads under wound bandages or wound sealing covers used in suction assisted wound healing. The goal has been to enhance the healing process though the properties and geometries of wound contact devices.
One such wound contact device comprises a permeable material having a plurality of dimple voids formed in the wound contact side of the device, wherein the dimple voids are preferably disposed in a randomly spaced pattern. Because the contact device comprises a permeable material with interconnecting interstices, it can effectively transport deleterious wound exudates away from the wound surface. The device can be cut to size for a wound, and the cut piece placed in contact with the tissue of the wound under a bandage or under a sealing cover. The dimple voids provide empty space into which new tissue can grow without becoming excessively intertwined with the permeable material, in contrast to the intertwining growth that is known to occur with porous foam pads. The contact elements between the dimple voids provide a main tissue contact surface. The permeable material of the contact device provides sufficient resistance to compression to keep the dimple voids from entirely collapsing when suction or other compacting pressure is applied to the wound dressing. Additionally, the contact device maintains the dimple voids in the presence of moisture.
In addition to providing empty growth space, the combination of the dimple voids and the contact elements imposes a beneficial strain on the tissue when suction is applied to the wound dressing, pulling the tissue into a catenary-like shape within the voids. These forces and the resulting strain imposed on the tissue are believed to stimulate new tissue growth more effectively than the forces obtained in suction therapy using wound dressings that have generally flat surfaces when suction is applied.
It would be advantageous to provide an improved wound contact device comprising a permeable structured material and a wound contact layer affixed to a side of the structured material forming a wound contact surface, with a plurality of voids extending through the contact layer to a depth within the structured material and defining wound contact elements on the wound contact surface. In one embodiment, it would be advantageous to provide a wound contact device having a wound contact surface adapted to prevent healthy tissue growth from becoming entangled with the device. In another example, it would be advantageous to provide a wound contact device having a wound contact surface adapted to debride dead tissue out of a wound so that revascularized healthy tissue can grow. The nature of these improvements and the benefits they confer will be apparent from the description and sample embodiments which appear below.
The present invention provides a wound contact device for use in a wound dressing. The device is particularly adapted for use in a dressing where suction or negative pressure therapy is used to promote healing. The wound contact device comprises a permeable material having a wound contact surface, the wound contact surface comprising a plurality of depressions and/or voids interposed between a plurality of wound contact elements. The material may include a plurality of fibers coupled to one another. The material may alternatively include a polyester felt material.
An embodiment of the present invention provides a wound contact device comprising a thin film affixed to the permeable material for forming the wound contact surface, the thin film covering the wound contact elements and having apertures corresponding to the depressions or voids, the thin film being essentially smooth (i.e., having essentially no surface gaps) so as to resist entanglement with new tissue growth. Another embodiment of the present invention provides a wound contact device comprising a thin fabric layer affixed to the permeable material for forming the wound contact surface, the fabric layer covering the wound contact elements and having apertures corresponding to the depressions or voids, the fabric layer having small gaps or openings so as to enable entanglement with and debriding of necrotic tissue, the openings being smaller than the voids in the wound contact device.
These and other aspects and objects will become apparent from the following description.
The accompanying drawings, which are incorporated herein and constitute a part of this specification, illustrate preferred embodiments of the invention, and together with the general description given above and the detailed description given below, serve to explain features of the invention.
A wound dressing is provided comprising a wound contact device having a structured material and a discontinuous contact surface or layer for promoting tissue growth. The contact surface or contact layer includes wound contact elements and voids or depressions interposed between the wound contact elements. The structured material maintains the voids when the wound contact device is placed against the wound so that the empty space or void volume within the voids permits space for tissue growth.
The wound dressing, and in particular the structured material of the wound contact device, is sufficiently physically rugged to resist flattening when forces are imposed to press the wound contact device against the wound surface. Forces pressing the wound contact device against the wound surface include, but are not limited to, suction applied to the wound dressing during application of negative pressure wound therapy. In addition, the material of the wound contact device, and in particular the, structured material, retains its structure when exposed to aqueous or other bodily fluids, in contrast to many traditional wound contact device materials that soften and lose their geometric form as they moisten.
The structured material of the wound contact device is permeable, allowing the communication of suction proximal to the wound surface and allowing for fluids to be drawn from the wound. The structured material can be absorbent, but is able to retain its structure and resist change in the presence of moisture and aqueous liquids.
The voids preferably extend into the structured material to a depth of at least 0.1 mm above the wound surface when the wound contact device is placed against the surface of the wound. More preferably, the depth of the voids is between about 0.2 mm to about 5 mm. The width of the voids, as defined by the empty space between contact elements adjacent to the voids, is preferably greater than 0.1 mm. More preferably, the width of the voids is between about 0.5 mm to about 10 mm. The voids may be of any cross-sectional shape, including oblong, round, irregular, or square, as shown for example in
Wound healing is recognized as a complex process. When a wound dressing or wound contact device having interposed wound contact elements and voids, as described herein, is forced against a wound surface, a number of biological processes are believed to occur, particularly when the wound dressing is subjected to suction. In suction wound therapy with a wound contact device or wound dressing as described herein, mechanical strain is applied to the underlying tissue. Suction in combination with apertures in the wound contact surface of the wound contact device impose a force resulting in a catenary shape on the tissue, whereby tissue is stretched partially into the voids between the contact elements. The stretched tissue and cells are under strain, which is known to produce cellular proliferation and migration. Growth of new granular tissue is further encouraged by removal of excess fluid exudates away from the wound surface by suction. Periodic replacement of the wound contact device with another wound contact device having randomly spaced dimples, so that different portions of the wound are successively in contact with the contact elements and/or exposed to the voids, encourages growth throughout the wound surface.
A fibrous material can be used to form the structured material of the wound contact device, the fibrous material having all the flexibilities provided by the textile arts. Fibrous textiles can be formed into a structure suitable for use in a wound contact device by various methods. Among these methods are knitting, weaving, embroidering, braiding, felting, spunbonding, meltblowing, and meltspinning. Each of these methods can be further adapted to produce a material having a discontinuous surface structure including wound contact elements and void spaces, as described herein. Such structures can be imparted during production of the textile material by, for example, applying molten fibers directly to a mold as in meltblowing. Alternatively, the structures can be formed by working a formed textile material after production by, for example, heat stamping or vacuum forming. Further, fibrous or textile material can be mixed with an adhesive and sprayed onto a textured surface.
The versatility of fibrous textiles also extends to their easy adaptation to composite applications. Individual fiber materials may be varied to optimize a physical parameter such as rigidity or flexibility. Individual fiber materials can also be selected for their known ability to assist in wound healing. Examples of such fiber materials are calcium alginate and collagen. Alternatively, fibers may be treated with known wound healing agents such as hyaluronic acid or antimicrobial silver. The ratio of the fiber materials can be varied to suit the requirements of the wound. According to one desirable aspect of the invention, different fibers with various wound healing properties may be added as desired.
A wound contact device comprising fibers also has the advantage of being somewhat conformable to the wound surface, which is often irregular. Moreover, fibrous textiles can be formed into structures having numerous small interconnected interstices between coupled or intertwined fibers. Such interconnected interstices enable or assist in the transport of deleterious wound exudates away from the wound surface. The number, size, and orientation of interstices can be controlled and optimized depending on the manufacturing method used to produce the fibrous device.
In an example, such as shown in
Other fibrous structures that are anticipated as beneficial additions include: (1) fluid absorbing fibers; (2) non-adsorbent fibers; (3) bio-absorbable fibers; (4) wicking fibers to wick fluid away from the surface of the wound; (5) fibers with known healing effects, such as calcium alginate; (6) bio-erodable fibers for the controlled release of a curative agent; (7) conductive fibers for the delivery of an electric charge or current; (8) adherent fibers for the selective removal of undesirable tissues, substances, or microorganisms; and (9) non-adherent fibers for the protection of delicate tissue.
An exemplary embodiment of a wound contact device is illustrated in
In use, the channeled wound contact device 100 is pressed against a wound into intimate contact with the wound surface. A pressure of 0.1 PSI (5 mm Hg) or more, applied by suction or other means, is desirably applied to press the wound contact surface 110 against the surface of the wound so that the wound contact elements 106 are in intimate contact with injured tissue and the voids 104 remain clear above the wound surface to receive new tissue growth. Preferably, suction is applied in the range of between about 0.25 PSI (12 mm Hg) and about 5 PSI (260 mm Hg). More preferably, suction is applied at a level between about 0.67 PSI (35 mm Hg) and about 1.45 PSI (75 mm Hg).
As best illustrated in
Dimple voids 304 can be formed in a variety of regular or irregular shapes, such as illustrated in
In an embodiment, the structured material 302 of the wound contact device 300 is formed from Masterflo RTM. In another embodiment, the structured material 302 is formed from polyester needle felt. The structured material 302 has a thickness in the range of about 1.0 mm to about 1.5 mm. The dimple voids 304 are formed in the material 302, the dimple voids 304 having an average depth of about 0.75 mm and an average diameter of about 2 mm. The dimple voids 304 may be formed into the material 302 prior to attachment of the wound contact layer 320, or the wound contact layer 320 can be attached to the material 302 first and the voids 304 subsequently formed through the wound contact layer 320 (to create the apertures 312) and further into the material 302 (to create the dimple voids 304).
The wound contact device 300 is replaced periodically, usually after being in place on the wound for time periods ranging from several hours to a few days. Because tissue growth preferentially occurs in the regions of the voids 304 compared with the regions of the wound contact elements 306, the dimple voids 304 and wound contact elements 306 of a replacement wound contact device 300 are preferably not positioned to be generally aligned with the regions where the dimple voids 304 and wound contact elements 306 of the previous wound contact device 300 had been. Thus, in order to encourage the generation of new tissue across all regions of the wound, several techniques can be employed to vary the positioning of the dimple voids 304 and contact elements 306 within the wound. In an example, the dimple voids 304 can be arranged randomly so that dimple voids 304 will not be aligned from one portion of wound contact device 300 to another. In another example, wound contact devices 300 can be provided with dimple voids 304 having different diameters, either within the same wound contact device 300 or between successive wound contact devices 300. In yet another example, wound contact devices 300 can be provided with dimple voids 304 having a different spacing, either within the same wound contact device 300 or between successive wound contact devices 300.
As illustrated in
When using the wound contact device 300, the dimple voids 304 can be partially filled with therapeutic substances. For example, antiseptic substances might be placed in voids. 304 for treating infected wounds. Further, biologic healing agents could be delivered in the voids 304 to improve the rate of new tissue formation. Additionally, the wound contact device 300 could have a different function on each side. In an example, one side of the contact device 300 could be optimized for the growth of new tissue, while the other side of the contact device 300 could be optimized for the delivery of anti-microbial agents. In another example, one side of the contact device 300 could have small gaps or roughened areas optimized for debriding necrotic tissue from a wound and the other side of the contact device 300 could have contact elements 306 having a smooth contact surface 310 for preventing entanglement of new tissue growth.
As shown particularly in
The wound contact surface 310 comprising the film layer 320 can be made even more releasable from the healing wound tissue by applying a coating, such as a hydrogel, to the wound contact layer 320. In a preferred embodiment, the film is a plastic film and a polymeric hydrogel is cross-linked with the plastic film to form a hydrogel laminate that resists de-lamination and potential retention of the gel in the wound when the wound contact device 300 is removed and changed. The gel provides the wound contract layer 320 of the contact device 300 with a cool, wet, and slippery contact surface 310 that allows the wound contact device 300 to be removed from the wound with minimal tissue disruption and discomfort.
In an embodiment, the film layer 320 can comprise a dissolvable film. One or more drugs and other agents can be integrated to the dissolvable film. When the film dissolves in the presence of moisture, the drug or agent is released.
As shown particularly in
A preferred fabric sheet for forming the contact layer 620 is a spunbonded (non-woven) low-lint 100% polyester fiber fabric, although other synthetic fabrics such as spunbonded polypropylene and spunbonded composite fibers can be highly calendered to sufficiently fine flat surfaces. The fabric preferably has a thickness of less than about 0.020 inches (0.51 millimeters), and more preferably has a thickness of less than about 0.004 inches (0.102 millimeters).
The respective properties of the different contact layers 620 and 320 in early and late stage healing, respectively, make it advantageous to provide a progressive healing kit containing one or more wound contact devices 600 comprising the fabric contact layer 620 having small surface gaps or roughened areas, along with one or more wound contact devices 300 comprising the film contact layer 320 having essentially no surface irregularities or gaps. The wound contact devices in the kit may be used to remove necrotic tissue earlier in the healing process with the contact devices 600 comprising the fabric contact layers 620, and to reduce patient discomfort later in the healing process with the contact devices 300 comprising the film laminate contact layers 320.
A dimpled contact device, such as the wound contact device 300, is illustrated by
As illustrated in
Even after removal of the necrotic tissue, the wound may still be infected, thus inhibiting healing. The material 502 of the wound contact device 500 can comprise an antimicrobial agent such as antimicrobial silver, which is useful in killing bacteria. Removal of necrotic tissue and the killing of bacteria residing in the wound can help the wound transition to the proliferative phase, when new tissue is formed. Continued use of the wound contact device 500 including an antimicrobial agent can maintain a low bacteria level in the wound and accelerate the healing, encouraging growth and proliferation of new cells and tissue. New cell growth can further be encouraged by addition of other growth enhancing materials to the material 502 of the wound contact device 500.
As shown particularly in
As illustrated in
As illustrated in
Treatment with a wound contact device as described herein is most effective when the contact device is held in intimate contact with the wound surface. The contact device is preferably held with a pressure of at least about 0.1 PSI (5 mm Hg). Typically, the wound area is sealed with a conformable cover and suction is applied to the dressing under the cover. The dimpled wound contact device 300 is particularly well-adapted for application of suction, because the material 302 is adapted to retain its structure, including the voids 304 so as to maintain empty space therein, under the compressive force of suction and in the presence of moisture and other wound exudates. The wound contact device 300 is disposed in the wound such that the wound contact surface 310 is in contact with the wound surface and the voids 304 are open above the wound surface, as generally depicted in
Case Study 1
Patient A is a 70 year old male with a Stage IV decubitus ulcer on the right hip with significant undermining. A wound contact device including the structured material and wound contact surface of the present invention was applied to the wound and an adhesive film was placed over the wound and the wound contact device. A suction of about 1.1 PSI was applied beneath the adhesive film to impart a force upon the wound. The suction was maintained substantially continuously. The wound contact device was replaced every two to four days. After use of the wound contact device for 30 days, the undermined portion of the wound had virtually healed and the area of the wound opening had decreased from 66 square centimeters to 45 square centimeters. A split thickness skin graft was applied to the wound.
Case Study 2
Patient B is a 50 year old male with a facture of the right ankle with exposed bone. A plate was used to reduce the fracture and a rectus abdominus free flap was performed to cover the exposed bone and hardware. The flap only partially survived resulting in an open wound with exposed bone and hardware. A wound contact device of the present invention was applied to the wound and an adhesive film was placed over the wound and the contact device. A force was applied to the contact structure by the application of an ace bandage wrapped around the ankle and/or by the application of suction. The suction force was generally applied for about half of the day and the force of the bandage wrap was maintained for the remainder of the day. For a number of days, the bandage wrap was solely used to impart the force. When the force was imparted by suction, a suction of between about 1 PSI and about 2 PSI was used. In less than 2 weeks, new tissue had grown over the exposed hardware. Within 7 weeks, the wound area was reduced from 50 square centimeters to 28 square centimeters.
While preferred embodiments of the invention have been shown and described herein, it will be understood that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will occur to those skilled in the art without departing from the spirit of the invention. Accordingly, it is intended that the appended claims cover all such variations as fall within the spirit and scope of the invention.
This application is a continuation-in-part of U.S. patent application Ser. No. 10/982,346, filed on Nov. 5, 2004, which claims priority of U.S. Provisional Patent Application No. 60/561,745, filed on Apr. 13, 2004. This application also claims priority of U.S. Provisional Patent Application No. 60/819,146, filed on Jul. 7, 2006.
Number | Name | Date | Kind |
---|---|---|---|
2122121 | Tillotson | Jun 1938 | A |
2385207 | Hunn | Sep 1945 | A |
3042037 | Scales et al. | Jul 1962 | A |
3053252 | Wolf | Sep 1962 | A |
3307545 | Surowitz | Mar 1967 | A |
3568675 | Harvey | Mar 1971 | A |
3602220 | Bunyan | Aug 1971 | A |
3616156 | Scholl | Oct 1971 | A |
3703897 | Mack et al. | Nov 1972 | A |
3790433 | Baron | Feb 1974 | A |
3870041 | Davies | Mar 1975 | A |
3874387 | Barbieri | Apr 1975 | A |
3929135 | Thompson | Dec 1975 | A |
4180074 | Murry et al. | Dec 1979 | A |
4224945 | Cohen | Sep 1980 | A |
4252590 | Rasen et al. | Feb 1981 | A |
4323069 | Ahr et al. | Apr 1982 | A |
4382441 | Svedman | May 1983 | A |
4533352 | Van Beek et al. | Aug 1985 | A |
4542739 | Schafer et al. | Sep 1985 | A |
4906240 | Reed et al. | Mar 1990 | A |
4969880 | Zamierowski et al. | Nov 1990 | A |
4997425 | Shioya et al. | Mar 1991 | A |
5034006 | Hosoda et al. | Jul 1991 | A |
5059424 | Cartmell et al. | Oct 1991 | A |
5100396 | Zamierowski | Mar 1992 | A |
5106629 | Cartmell et al. | Apr 1992 | A |
5147338 | Lang et al. | Sep 1992 | A |
5176663 | Svedman et al. | Jan 1993 | A |
5261893 | Zamierowsk | Nov 1993 | A |
5358494 | Svedman | Oct 1994 | A |
5409472 | Rawlings et al. | Apr 1995 | A |
5437651 | Todd et al. | Aug 1995 | A |
5447505 | Valentine et al. | Sep 1995 | A |
5465735 | Patel | Nov 1995 | A |
5527213 | Tyler et al. | Jun 1996 | A |
5527293 | Zamierowski | Jun 1996 | A |
5549584 | Gross | Aug 1996 | A |
5556375 | Ewall | Sep 1996 | A |
5607388 | Ewall | Mar 1997 | A |
5633007 | Webb et al. | May 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5645081 | Argenta et al. | Jul 1997 | A |
5810756 | Montecalvo et al. | Sep 1998 | A |
5919180 | Raimondo | Jul 1999 | A |
6071267 | Zamierowski | Jun 2000 | A |
6126701 | Calogero | Oct 2000 | A |
6203563 | Fernandez | Mar 2001 | B1 |
6207875 | Lindqvist et al. | Mar 2001 | B1 |
6290685 | Insley | Sep 2001 | B1 |
6345623 | Heaton et al. | Feb 2002 | B1 |
6458109 | Henley et al. | Oct 2002 | B1 |
6468383 | Kundel | Oct 2002 | B2 |
6520982 | Boynton et al. | Feb 2003 | B1 |
6626891 | Ohmstede | Sep 2003 | B2 |
6682757 | Wright | Jan 2004 | B1 |
6685681 | Lockwood et al. | Feb 2004 | B2 |
6689931 | Etheredge, III | Feb 2004 | B2 |
6695823 | Lina et al. | Feb 2004 | B1 |
6737149 | Wintermantel et al. | May 2004 | B1 |
6752794 | Lockwood et al. | Jun 2004 | B2 |
6755807 | Risk, Jr. et al. | Jun 2004 | B2 |
6764462 | Risk, Jr. et al. | Jul 2004 | B2 |
6767334 | Randolph | Jul 2004 | B1 |
6800074 | Henley et al. | Oct 2004 | B2 |
6855135 | Lockwood et al. | Feb 2005 | B2 |
6885135 | Kanao et al. | Apr 2005 | B2 |
6897349 | Gibbins et al. | May 2005 | B2 |
6936037 | Bubb et al. | Aug 2005 | B2 |
6951553 | Bubb et al. | Oct 2005 | B2 |
7070584 | Johnson et al. | Jul 2006 | B2 |
7108683 | Zamierwoski | Sep 2006 | B2 |
7117869 | Heaton et al. | Oct 2006 | B2 |
7198046 | Argenta et al. | Apr 2007 | B1 |
7216651 | Argenta et al. | May 2007 | B2 |
7223899 | Sigurjonsson | May 2007 | B2 |
7273054 | Heaton et al. | Sep 2007 | B2 |
7338482 | Lockwood et al. | Mar 2008 | B2 |
7494482 | Orgill et al. | Feb 2009 | B2 |
7722582 | Lina et al. | May 2010 | B2 |
20010031943 | Urie | Oct 2001 | A1 |
20010043943 | Coffey | Nov 2001 | A1 |
20020065494 | Lockwood et al. | May 2002 | A1 |
20020115952 | Johnson et al. | Aug 2002 | A1 |
20020161346 | Lockwood et al. | Oct 2002 | A1 |
20030040691 | Griesbach, III et al. | Feb 2003 | A1 |
20030093041 | Risk, Jr. et al. | May 2003 | A1 |
20030176827 | Chandra et al. | Sep 2003 | A1 |
20040002676 | Siegwart et al. | Jan 2004 | A1 |
20040006319 | Lina et al. | Jan 2004 | A1 |
20040030304 | Hunt et al. | Feb 2004 | A1 |
20040039415 | Zamierowski | Feb 2004 | A1 |
20040054338 | Rybordi et al. | Mar 2004 | A1 |
20040064111 | Lockwood et al. | Apr 2004 | A1 |
20040064132 | Boehringer et al. | Apr 2004 | A1 |
20040093026 | Weidenhagen et al. | May 2004 | A1 |
20040122434 | Argenta et al. | Jun 2004 | A1 |
20040127862 | Bubb et al. | Jul 2004 | A1 |
20040127863 | Bubb et al. | Jul 2004 | A1 |
20050004534 | Lockwood et al. | Jan 2005 | A1 |
20050010153 | Lockwood et al. | Jan 2005 | A1 |
20050064021 | Rippon et al. | Mar 2005 | A1 |
20050070858 | Lockwood et al. | Mar 2005 | A1 |
20050131327 | Lockwood et al. | Jun 2005 | A1 |
20050209574 | Boehringer et al. | Sep 2005 | A1 |
20050228329 | Boehringer et al. | Oct 2005 | A1 |
20060041247 | Petrosenko et al. | Feb 2006 | A1 |
20060064049 | Marcussen | Mar 2006 | A1 |
20060128245 | Muth et al. | Jun 2006 | A1 |
20060129137 | Lockwood et al. | Jun 2006 | A1 |
20060189910 | Johnson et al. | Aug 2006 | A1 |
20060213527 | Argenta et al. | Sep 2006 | A1 |
20070021697 | Ginther et al. | Jan 2007 | A1 |
20070032778 | Heaton et al. | Feb 2007 | A1 |
20070038172 | Zamierwoski | Feb 2007 | A1 |
20070185426 | Ambrosio et al. | Aug 2007 | A1 |
20070219471 | Johnson et al. | Sep 2007 | A1 |
20070219489 | Johnson et al. | Sep 2007 | A1 |
20070219497 | Johnson et al. | Sep 2007 | A1 |
20070219513 | Lina et al. | Sep 2007 | A1 |
Number | Date | Country |
---|---|---|
2 161 235 | Jul 1973 | DE |
0619105 | Oct 1994 | EP |
2329127 | Mar 1999 | GB |
WO 8001139 | Jun 1980 | WO |
WO 9100718 | Jan 1991 | WO |
WO 0045761 | Aug 2000 | WO |
0137922 | May 2001 | WO |
WO 0134079 | May 2001 | WO |
02092783 | Nov 2002 | WO |
03057071 | Jul 2003 | WO |
WO 03057070 | Jul 2003 | WO |
WO 03057070 | Jul 2003 | WO |
WO 2004037334 | May 2004 | WO |
2005046761 | May 2005 | WO |
WO 2005046762 | May 2005 | WO |
Number | Date | Country | |
---|---|---|---|
20080177253 A1 | Jul 2008 | US |
Number | Date | Country | |
---|---|---|---|
60819146 | Jul 2006 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10982346 | Nov 2004 | US |
Child | 11825397 | US |